ABSTRACT: Acidification of the internal poly(lactide-co-glycolide) (PLGA) microenvironment is considered one of the major protein stresses during controlled release from such delivery systems. A model protein, bovine serum albumin (BSA), was incubated at 378C for 28 days to simulate the environment within the aqueous pores of PLGA during the release phase and to determine how acidic microclimate conditions affect BSA stability. Size-exclusion high performance liquid chromatography (SE-HPLC), SDS-PAGE, and infrared spectroscopy were used to monitor BSA degradation. BSA was most stable at pH 7, but rapidly degraded via aggregation and hydrolysis at pH 2. These simulated degradation products were nearly identical to that of unreleased BSA found entrapped within PLGA 50/50 millicylinders. At pH 2, changes in BSA conformation detected by various spectroscopic techniques were consistent with acid denaturation of the protein. By contrast, at pH 5 and above, damage to BSA was insufficient to explain the instability of the protein in the polymer. Thus, these data confirm the hypothesis that acid-induced unfolding is the basis of BSA aggregation in PLGA and the acidic microclimate within PLGA is indeed a dominant stress for encapsulated BSA. To increase the stability of proteins within PLGA systems, formulations must protect against potentially extreme acidification such that native structure is maintained.
INTRODUCTION
Recent advances in biotechnology have lead to an explosion in the production of recombinant therapeutic proteins as potential drug candidates. The development of safe and effective delivery options for these proteins, however, has not been as progressive. Currently, injection is the most common method used to deliver therapeutic proteins due in part to poor absorption, low bioavailability, and short in vivo half-lives through other routes of administration. 1 Patients that require chronic treatment with such therapeutics are often subjected to daily injections. A controlled-release delivery system, which delivers the protein drug slowly and continuously for weeks to months, is a desirable alternative to the present standard and would improve patient compliance, comfort, and safety.
Biodegradable and biocompatible polymers, such as poly(lactide-co-glycolide) (PLGA), have gained much attention and research focus for use in the controlled release of therapeutic proteins. PLGA has been used for many years in various medical applications (i.e., surgical sutures) and the safety of the polymer is well-established. [2] [3] [4] A variety of delivery systems, such as microspheres and millicylindrical implants, can be produced using PLGA, and specific release profiles may be generated through manipulating the properties of the polymer. 5 PLGA has been used effectively in the controlled release of low molecular weight steroids 6, 7 and peptides. 8, 9 By contrast, the use of PLGA in the delivery of therapeutic proteins, which are more complex than small peptides in both structure and stability, has been less successful. Nutropin Depot 1 (Alkermes-Genetech) is the only FDA-approved product that utilizes PLGA for the controlled release of a therapeutic protein, recombinant human growth hormone. 10 However, this product is no longer marketed.
One of the greatest limitations in the development of PLGA controlled-release systems is the incomplete release and instability of the encapsulated protein. Incomplete in vitro protein release has been observed with many PLGA delivery systems and is attributed to protein instability within the PLGA device. 1, [11] [12] [13] Protein instability during the release phase of PLGA systems is not completely understood, though the dominant protein stresses during release are hypothesized to include (i) increased protein mobility during the hydration of the delivery system and (ii) acidification of the PLGA microclimate. 13 During processing, PLGA devices are typically dried to remove organic solvents required for encapsulation. 14 It is well-known that the secondary structure of proteins may be compromised during this dehydration step, leading to partially unfolded and aggregate-prone conformations. 15, 16 Upon rehydration, the protein must refold back to the native state and this process competes with the formation of nonnative intermolecular interactions that drive protein aggregation. As the PLGA system imbibes water, the high protein concentrations reached during rehydration of PLGA matrix should favor aggregation over refolding. Water uptake also catalyzes the erosion of the polymer via the hydrolysis of ester linkages, producing lactic and glycolic acids. 5, 17 These breakdown products quickly acidify the aqueous pores where encapsulated protein resides in PLGA systems [18] [19] [20] and have been observed to decrease the internal system pH to values less than 3. 19, 21 Exposure of the protein to acidic conditions may lead to perturbations in the native structure of the protein, which in concert with high protein concentration could foster rapid aggregation.
In this study, we examined the influence of the acidic microclimate conditions on the structural stability of bovine serum albumin (BSA). BSA is a commonly used model protein for PLGA-based controlled-release studies, and BSA instability within PLGA has been well-documented. 12, 13 BSA degradation was examined as a function of protein concentration, buffer pH, and buffer ionic strength during incubation for 1 month at 378C to simulate the conditions that exist in PLGA delivery systems during the release phase. The degradation of the protein was characterized and compared to that observed with PLGA-encapsulated BSA. Structural analysis of BSA under the solution conditions used in this study was thoroughly performed using infrared, circular dichroism (CD), and second derivative ultraviolet (UV) absorbance spectroscopic methods to help elucidate the underlying mechanisms of instability.
MATERIALS AND METHODS
BSA (lyophilized powder, Fraction V) was purchased from Sigma and used without further purification. All chemicals were of reagent grade or higher, and obtained from Sigma unless otherwise noted.
Sample Preparation and Incubation
BSA was dissolved in 10 mM potassium phosphate (pH 7.0) and dialyzed (Slide-A-Lyzer dialysis cassette, 10 kDa MWCO, Pierce Biotechnology, Inc., Rockford, IL) against a large volume of the appropriate buffer at 48C. Low-ionic strength buffers contained 10 mM potassium phosphate and 0.02% (w/v) sodium azide, and high-ionic strength buffers contained 10 mM potassium phosphate, 150 mM sodium chloride, and 0.02% (w/v) sodium azide. Samples were prepared at pH 2, 5, and 7 and at protein concentrations of 10, 40, and 100 mg/mL under both low-and high-ionic strength conditions. When necessary, samples were concentrated using an Amicon device equipped with a 30 kDa MWCO membrane (Whatman, Inc., Florham Park, NJ) under N 2 gas. Protein concentration was determined by A 279 (e ¼ 0.667 mL mg À1 cm
À1
provided by the supplier), and samples were centrifuged (20000g for 10 min at 48C) prior to measuring protein concentration. For each incubation condition, the samples were filtered (0.2 m cellulose acetate) and aliquots (0.2 mL) were prepared in 0.25 mL PCR tubes, which were then wrapped with parafilm to prevent sample evaporation. For each solution condition and incubation time-point, triplicate sample tubes were prepared. The sample tubes were placed vertically in a rack and stored in a 378C incubator.
SE-HPLC
A Hewlett-Packard 1090 HPLC (250 ml injection syringe and diode array UV detection), equipped with a TSK-Gel 3000SW XL column (Tosoh Biosciences LLC, Montgomeryville, PA) was used for size-exclusion high performance liquid chromatography (SE-HPLC) analysis. The mobile phase was 10 mM potassium phosphate, 150 mM sodium chloride and 0.02% (w/v) sodium azide, pH 7.0, which was filtered (0.2 m membrane, Whatman, Inc.) and degassed prior to use. Samples were centrifuged (20000g for 10 min at 48C) to remove insoluble aggregates and diluted in mobile phase buffer prior to application to the column. The flow rate during analysis of protein samples was 0.6 mL/min, and protein was detected at 214 nm. To quantitate loss in BSA monomer, chromatograms were exported to Bomem Grams/ 32 software (version 4.04, 1996) and peak areas were determined by integration. Loss in peak area was determined as a percent of the peak area for the control (day 0) sample.
Infrared Spectroscopy
Infrared spectra were collected using a Bomem Prota spectrophotometer purged with dry air. BSA solution samples (40 mg/mL), BSA gels, or precipitated protein samples were applied to a 6 m path length CaF 2 cell. For each protein and buffer sample, a 128-scan interferogram was collected in single-beam mode with a resolution of 4 cm À1 at 378C. Thermal control of the sample was maintained with a custom-made thermal cell attached to a circulating water bath. Water vapor and buffer spectra were subtracted as previously described. 22 Raw data were transformed to second derivative spectra using Bomem Grams/ 32 software (version 4.04, 1996) to examine the amide I region (1600-1700 cm À1 ) as described elsewhere. 22 
Far UV CD Spectroscopy
Samples were prepared at a BSA concentration of 0.1 mg/mL and far UV CD scans were collected using an AVIV Model 62DS spectrometer. Data were collected in millidegrees from 190 to 260 nm at 0.5 nm intervals using a 0.1 cm path length quartz cuvette at 378C. After buffer subtraction, the raw data were transformed to mean residue ellipticity (MRE, deg cm 2 /dmol). Deconvolution of far UV CD data was performed using CD Pro software.
Second Derivative UV Absorbance Spectroscopy
Samples were prepared at 0.5 mg/mL and placed in a quartz cuvette with a 1 cm path length. Absorbance spectra (200-350 nm, 240 nm/min scan rate) were collected using a Beckman DU-640 spectrophotometer at 378C. Sample temperature was controlled by using a thermal jacket attached to a circulating water bath, and the temperature of the sample was verified using a thermometer with a Type T thermocouple (Omega Engineering Inc., Stamford, CT). The appropriate buffer spectrum was subtracted from each protein absorbance spectrum. For chemical denaturation studies, BSA was incubated with 5.5 M guanidine hydrochloride (GdnHCl) at pH 7 for 24 h at room temperature prior to analysis. The concentration of GdnHCl was determined by refractometry. Data were then exported and transformed to second derivative spectra using Bomem Grams/ 32 software (version 4.04, 1996) using a method previously described. 23 
SDS-PAGE
BSA samples were subjected to SDS-PAGE analysis using precast gradient gels (4%-20% Tris-HCl/glycine, Bio-Rad Laboratories, Inc., Hercules, CA) or hand poured 7.5% gels. Samples were diluted 1:1 in Laemmli sample buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% Bromophenol blue), with or without 750 mM b-mercaptoethanol, and boiled for 5 min (with b-mercaptoethanol) or 1 min (without bmercaptoethanol) prior to loading. Gels were electrophoresed for 1 h 10 min at 180 v and then stained with Coomassie blue to visualize the protein bands.
PLGA Millicylinder Preparation, Incubation, and BSA Extraction BSA was encapsulated at 10% (w/w) in PLGA millicylinders (50:50, i.v. 0.61 dl/g, Birmingham Polymers, Inc., Birmingham, AL) by a solvent extrusion method. 13 Briefly, a uniform suspension of sieved BSA powder (<90 mm) in 50% (w/w) polymer/acetone solution was loaded into a 5 mL syringe and extruded into silicone tubing (0.8 mm I. D.). The extruded suspension was dried at room temperature for 24 h followed by further drying in a vacuum oven at 458C for another 24 h. The silicon tubing was then cut and millicylinders were retrieved. In vitro release studies were carried out at 378C under mild agitation conditions. Millicylinders (10 Â 0.8 mm, 5-7 mg total weight) were placed in 1.5 mL eppendorf tubes and incubated with 1 mL PBST (7.7 mM Na 2 HPO4, 2.3 mM NaH 2 PO4, 137 mM NaCl, 3 mM KCl, pH 7.4 with 0.02% Tween-80) for 2 weeks. Release medium was then removed and the millicylinder was dissolved in acetone and centrifuged. It has been shown previously that this acetone extraction method does not significantly affect the structure nor induce aggregation of BSA. 13 The precipitated protein pellets were washed twice with acetone and air-dried, after which 1 mL PBST was then added. The resulting suspension was incubated at 378C under mild agitation conditions for 1 h to remove any soluble protein. The remaining precipitate was analyzed by infrared spectroscopy.
RESULTS AND DISCUSSION
Characterization of BSA Degradation during Incubation at 378C
Degradation of BSA was examined under solution conditions that simulate the environment within PLGA delivery systems during various stages of release. Protein release from PLGA systems occurs in two phases. 5, 24 Initial exposure to the aqueous release media leads to the dissolution and then diffusion of protein molecules on or near the surface of the device, which often results in a burst effect in the release profile. 13 The second phase occurs as the polymer breaks down by means of hydrolytic scission of ester linkages and begins to erode. During PLGA erosion, the dehydrated protein rehydrates within the PLGA matrix. Thus, local protein concentration within the system may be quite high during the initial stages of rehydration, but is expected to become more dilute as the system continues to take up more water as the polymer degrades, pores are enlarged, and protein is released. 5 To simulate a range of protein concentrations anticipated in PLGA delivery systems during release, BSA concentrations of 100, 40, and 10 mg/mL were used in the current study. As a consequence of PLGA breakdown to lactic and glycolic acids during degradation and erosion, the internal PLGA environment can become acidic very rapidly. [18] [19] [20] [21] Therefore, neutral (pH 7), mildly acidic (pH 5), and acidic (pH 2) conditions were used to represent various stages of acidification. The effects of low-ionic strength (10 mM potassium phosphate) and high-ionic strength (10 mM potassium phosphate and 150 mM NaCl) buffers were also investigated.
BSA degradation under the above solution conditions was assessed initially by determining the level of native monomer after 28 days of incubation at 378C (Tab. 1). Under the conditions examined, BSA was most stable at pH 7 regardless of ionic strength and protein concentration since no significant loss in protein monomer was detected. At pH 5, approximately 5%-10% of BSA monomer was lost after 28 days of incubation. The protein concentration had little effect on the degradation of BSA at pH 5. The ionic strength at pH 5, however, had a slight effect on degradation as a greater amount of monomer was lost with the low-ionic strength samples (8.3-10.2%) when compared to the high-ionic strength samples (5.7-7.2%). BSA was the least stable under all pH 2 conditions and no monomer was detectable by the end of the incubation study.
To gain further insight into the kinetics and pathways of BSA instability, the degradation samples incubated at pH 2 were analyzed by SE-HPLC as a function of time during incubation at 378C. Loss of monomer proceeded rapidly under both low- (Fig. 1A ) and high- (Fig. 1B) ionic strength buffer conditions. The rate of degradation was much more rapid in 100 mg/mL than in 10 mg/mL or 40 mg/mL protein samples. For example, samples prepared at 100 mg/mL lost nearly 50% of monomeric BSA after only 1 day of incubation whereas samples prepared at 10 mg/ mL required about 5 days to degrade to the same extent. The ionic strength of the solution had a less dramatic effect on BSA stability where, in general, the rate of degradation was slightly higher in samples that contained 150 mM NaCl.
Inspection of the size-exclusion chromatograms revealed that the early loss of monomeric BSA was concomitant with the formation of large, soluble aggregates ( Fig. 2A) . Such aggregates were present in all pH 2 samples at some stage of the incubation study regardless of the BSA concentration or ionic strength (data not shown). The aggregates eluted in the void volume and suggest a molecular weight greater than 500 kDa based on the resolution of the column and calibration with molecular weight standards (data not shown). The aggregate peak area steadily increased in the first week of incubation at 378C. After this initial phase, however, the aggregate peak receded without a proportional recovery of BSA monomer. In some cases (100 mg/mL at both low-and high-ionic strength and 40 mg/mL high-ionic strength) the formation of a protein gel, which could not be dissolved by dilution or isolated by centrifugation, Samples formed a protein gel at the indicated time point, which hindered SE-HPLC analysis. Figure 1 . Loss of BSA monomer during incubation at 378C and at pH 2 under low-(A) and high-(B) ionic strength conditions. The * indicates the formation of a protein gel at the subsequent time point, which could not be analyzed by SE-HPLC. Data is shown as mean AE SE (n ¼ 3), and the error bars may be smaller than the data point in some cases.
prevented SE-HPLC analysis at further time points. It was also observed that the properties of the gels changed after extended incubation at 378C. Gelled samples stored for 3 months at 378C formed a white insoluble protein precipitate that settled at the bottom of the tubes (data not shown).
In addition to aggregation and gel formation, BSA fragmented during incubation at pH 2 and 378C in aqueous solution. Fragmented protein species, most likely due to hydrolysis of acid-labile Asp-Pro peptide bonds, 25 were seen in the sizeexclusion chromatograms as a shoulder on the monomer peak and as unresolved species eluting afterwards ( Fig. 2A) . Such signs of chemical degradation were observed to varying degrees in all samples incubated at pH 2 (data not shown). To further evaluate the fragmentation of BSA the samples were analyzed by SDS-PAGE, which showed the progressive loss of monomeric BSA and formation of several peptide species with molecular weights ranging from approximately 7 to 40 kDa (Fig. 2B) . The number and intensity of the fragments increased with the incubation time, indicating that BSA continued to hydrolyze throughout the incubation period. A small amount of intact BSA monomer was still detectable at the end of the incubation period, however, which suggests that the hydrolysis was not complete.
BSA degradation during incubation at pH 5 occurred mainly through the formation of insoluble precipitates that were observed in all samples for which there was a measurable monomer loss (Tab. 1). The secondary structure of the isolated aggregates, collected by centrifugation, was examined using infrared spectroscopy. Native BSA is a globular protein with a high content of a-helix structure (55-65%), 26, 27 represented by a large band at 1657 cm À1 in the second derivative infrared spectrum of the conformationally sensitive amide I region. 22 As expected, BSA in solution under mildly acidic conditions (pH 5) also demonstrated this characteristic a-helix band as well as turn (1680 cm À1 ), b-sheet (1684 and 1628 cm À1 ), and unordered (1638 cm À1 ) components (Fig. 3A) . The infrared spectrum of the insoluble protein had only a slight loss in the intensity at 1657 cm À1 (a-helix band) when compared to BSA in solution at pH 5. Additionally, the appearance of minor bands at 1695 and 1618 cm À1 due to the formation of intermolecular b-sheet bands were noted, which are indicative of nonnative aggregation. 22, 28 This data suggests that the BSA aggregates produced during incubation at pH 5 are relatively nativelike since only slight changes in the secondary structure were detectable. To determine if aggregates formed at pH 5 contained covalent crosslinks, the insoluble material was collected by centrifugation and analyzed using SDS-PAGE (Fig. 3B) . Most of the insoluble aggregates dissociated into monomeric BSA and high-molecular weight covalent species that were also present in the starting material, though a small amount of material remained in the well. Upon the addition of a reducing agent, the majority of these species dissolved and migrated through the gel. Taken together, these data indicate that the aggregates found at pH 5 are mainly noncovalent in nature with a small amount of disulfide cross-linked species.
Comparison of PLGA-and pH-induced BSA Degradation
Previous studies with BSA encapsulated within PLGA delivery devices, including microspheres as well as millicylinders, have demonstrated incomplete release profiles. 13 Specifically, BSA encapsulated within PLGA initially undergoes a burst release from the delivery system after which a minimal amount of protein is released at later time points. 13 Examination of the protein that remained entrapped within the PLGA revealed noncovalent aggregation as well as peptide bond fragmentation, indicative of exposure to a highly acidic environment. Thus, the incomplete release of BSA and other proteins from PLGA devices has been attributed in part to the acidification of the internal microclimate, which has been documented through various lines of research. The use of pH sensitive probes, 19, 21 electron paramagnetic resonance spectroscopy, 18 and potentiometric techniques 29 have demonstrated that the microenvironment within the PLGA becomes acidified during in vitro release with pH values as low as 2 reported. In experiments in which BSA was lyophilized from various solution pHs and then exposed to high relative humidity, it was found that only protein lyophilized from pH 2 leads to degradation products similar to that observed with PLGA systems. 13 Furthermore, the incorporation of a poorly water-soluble base, Mg(OH) 2 , prevents degradation and improves release of BSA in PLGA systems. 13 These observations support the hypothesis that the acidification of the internal microclimate of the PLGA system is a dominant stress for proteins during release, presumably due to acid denaturation of the protein.
To further examine this hypothesis, the products of BSA degradation within PLGA millicylinders were compared to those observed upon incubation under acidic conditions (pH 2). PLGA millicylinders were prepared with 10% BSA as described in the Materials and Methods. The Figure 3 . (A) FTIR analysis of insoluble BSA aggregates formed during 378C incubation at pH 5 and highionic strength buffer at 100 mg/mL protein concentration. BSA prepared at pH 5 low-ionic strength buffer at 40 mg/mL is also shown for comparison. Each spectrum is an average of three independent samples. (B) SDS-PAGE (7.5% gel) analysis of insoluble BSA aggregates formed after 28 days of incubation at 378C and pH 5 at 100 mg/mL under both low-and high-ionic strength conditions. Approximate molecular weights are indicated on the left and 5 mg of control BSA is shown (lane 1). Lanes 2 and 4 are approximately 10 mg of BSA incubated in low-ionic strength buffer, and lanes 3 and 5 are approximately 10 mg of BSA incubated in high-ionic strength buffer under both nonreducing (NR) and reducing (R) conditions. Protein bands were visualized by Coomassie blue staining. millicylinders were then exposed to PBST release medium for 2 weeks at 378C, after which no further protein was released from the device. The trapped BSA, which was the insoluble protein residue and determined to be 53% of total encapsulated BSA, was extracted and analyzed by infrared spectroscopy. The infrared spectrum for the extracted aggregates from the PLGA millicylinders revealed an immense loss of native a-helix content (1657 cm
À1
) and a high level of intermolecular bsheet (1618 and 1695 cm À1 ) compared to BSA in solution (Fig. 4) . The BSA aggregates extracted from the PLGA millicylinders have highly disrupted secondary structure, presumably due to nonnative contacts and extensive aggregation. The extracted protein from the PLGA millicylinders was also compared to the BSA aggregates observed during incubation of the protein at 378C and pH 2. It is anticipated that if acidification is the dominant pathway of BSA instability within the PLGA millicylinders then incubation under acidic conditions (pH 2) should produce similar degradation products, including protein aggregates. In fact, the infrared spectrum of the BSA gels detected at pH 2 revealed nearly identical spectral properties, namely extensive loss of a-helix and concomitant formation of intermolecular b-sheet structures, as to that of the protein extracted from the PLGA (Fig. 4) . It is interesting to consider the BSA aggregates detected during incubation under only mildly acidic conditions (pH 5) showed only minimal structural changes in comparison (Fig. 3A) . Taken together, these data suggest that mildly acidic conditions within the PLGA device would not be sufficient to produce the aggregates observed in the extracted material. Rather, the microclimate must acidify to a much lower pH to produce the aggregates found trapped within the PLGA matrix in this study. It is important to note that BSA gels were not observed in the sample extracted from PLGA millicylinders. BSA gels incubated for an extended period of time (3 months) at 378C, however, lost gel-like properties and formed a white precipitate that settled on the bottom of the tube. Infrared spectroscopic analysis of the precipitated BSA revealed similar spectral characteristics to that of the gelled BSA (data not shown).
As discussed above, similarities are expected between BSA exposed to acidic (pH 2) solution conditions and that extracted from PLGA millicylinders if acidification of the microclimate pH during release is a dominant protein stress. Previous studies with BSA encapsulated within PLGA-delivery devices revealed extensive hydrolysis of the protein. 13 In this study, we observed unresolved species eluting after the BSA monomer by SE-HPLC during incubation at pH 2 that suggested fragmentation of the protein (Fig. 2A) . Additionally, we confirmed that BSA had undergone hydrolysis by SDS-PAGE, in which a variety of protein fragments ranging from 7 to 40 kDa were seen (Fig. 2B) . In contrast, BSA samples that were incubated under only mildly acidic conditions (pH 5) did not display detectable fragmentation in SDS-PAGE gels (Fig. 3B) . These results follow the trend observed with the extent of secondary structure perturbation in the insoluble BSA aggregates at pH 2 (Fig. 4) and 5 (Fig. 3A) , indicating that exposure to acidic conditions (pH 2) are responsible for the degradation found within PLGA millicylinders.
To better understand the structural basis of BSA instability under acidic conditions, the kinetics of secondary structural transitions accompanying BSA aggregation at pH 2 were also examined by infrared spectroscopy. BSA prepared at pH 2 demonstrated a high content of a-helix as well as turn, b-sheet and unordered structures 22 ( Fig. 5) . BSA quickly loses native secondary structure (primarily a-helix content) when incubated at 378C and pH 2, and forms nonnative aggregates signified by intermolecular b-sheet in the infrared spectra. 28 After only 2 h of incubation Figure 4 . FTIR analysis of BSA aggregates from pHand PLGA-induced stresses. Aggregates extracted from PLGA millicylinder after 2 weeks of incubation at 378C in release media compared to BSA gel produced from incubation at pH 2 for 7 days at 378C (100 mg/mL and high-ionic strength buffer). BSA prepared at pH 2, 40 mg/mL, and high-ionic strength buffer, is also shown for comparison. Each spectrum represents an average of three independent samples.
at 378C, the intensity of the a-helix band was noticeably reduced and continued to decrease in a time-dependent manner. The formation of new bands at 1695 and 1618 cm À1 , indicative of intermolecular b-sheet structures, was also observed. This trend continued until 12 h of incubation, after which there was little change until the protein gel formed (day 7). The protein gel demonstrated an even greater loss in native ahelical content and a larger amount of intermolecular b-sheet compared to the 24 h spectrum. All gelled BSA samples, 100 mg/mL (low-and highionic strength buffer) and 40 mg/mL (high-ionic strength buffer), had nearly identical infrared spectra (data not shown).
Effect of Solution Conditions on BSA Structure
To better understand how solution conditions affect degradation pathways of BSA, the structure of the protein was examined under the solution conditions employed in this study. The secondary structure of BSA was evaluated using infrared spectroscopy under both low- (Fig. 6A ) and high- (Fig. 6B) ionic strength conditions. At pH 7, BSA is composed of a high amount of a-helix content by a strong band at 1657 cm À1 and other bands attributed to b-sheet structures (1691, 1640, and 1631 cm À1 ), turn (1681 cm À1 ), and random coil (1650 cm À1 ). 22 The ionic strength of the buffer did not affect the secondary structure of BSA at either pH 5 or 7, nor were there substantial differences in the spectra for samples between these two pHs. Visual inspection of the Fourier-transform infrared spectroscopy (FTIR) spectra of BSA at pH 2, however, revealed subtle changes. In addition to minor structural rearrangements of b-sheet components (1638 to 1618 cm À1 ), the position of the ahelix band appeared to shift slightly from 1657 to 1655 cm À1 , and a small decrease in intensity of this band was also noted. These structural changes were most pronounced in the low-ionic strength samples, in which the bandwidth of the a-helix band also appeared to increase. Analysis of the fourth derivative of the infrared spectra resolved a new band at 1649 cm À1 , assigned to unordered structure, 22 which was detectable only in the low-ionic strength samples at pH 2 (data Figure 5 . Changes in the secondary structure of BSA monitored by FTIR. The sample was prepared at 100 mg/ mL in pH 2 high-ionic strength buffer and spectra were collected at various time-points during incubation at 378C until and gel formation (day 7). Arrows indicate the loss of a-helix (1657 cm À1 ) and formation of intermolecular b-sheet (1618 and 1695 cm À1 ), respectively. Each spectrum represents an average of three independent samples. Figure 6 . FTIR of BSA (40 mg/mL) prepared under various pHs in low-(A) and high-(B) ionic strength buffers. Data were collected at 378C and each spectrum represents an average of at least three independent samples. not shown). This suggests that BSA underwent unfolding at pH 2 and low-ionic strength as native a-helix was converted to unordered structures. The lack of this new peak in the fourth derivative of the high-ionic strength samples indicates that BSA retains more native secondary structure under these solution conditions.
To confirm the FTIR results, far UV CD spectroscopy was also used to examine the secondary structure of BSA as a function of the solution conditions. The far UV CD spectra of BSA at pH 7 in both high- (Fig. 7B ) and low-ionic strength buffers (Fig. 7A) had two strong negative bands at 208 and 222 nm as well as a strong positive band at 195 nm. These properties are attributed to a high content of a-helix structure in proteins. 30 At pH 5, a small decrease in the intensity of the 208 and 222 nm bands was seen at both ionic strengths. The spectrum for BSA under pH 2 and low-ionic strength conditions had a large decrease in intensity of all a-helix bands and a blue shift in the 208 nm band. This points to a substantial loss in native structure at pH 2 and low-ionic strength. In contrast, the spectrum of BSA at pH 2 and highionic strength was only slightly different than that for the protein at pH 7. These changes were quantitated by deconvoluting the far UV CD data using CD Pro software (Tab. 2). In agreement with the visual inspection of the spectra, BSA contained a high amount of a-helix structure at both pH 5 and 7 with no significant effect induced by the ionic strength of the solution. BSA prepared at pH 2 and low ionic strength lost over 15% of native a-helical content, and gained content in all other structure with the greatest increase in turn (9.0% to 18.8%). BSA at pH 2 and high-ionic strength, however, did not differ in secondary structure content from pH 7 (Tab. 2). Thus, the presence of 150 mM NaCl in the protein solution at pH 2 resulted in much less disruption in the secondary structure of the protein compared to low-ionic strength samples.
Changes in the tertiary structure of BSA were examined by second derivative UV absorption spectroscopy, which is sensitive to the polarity, and thus the solvent exposure, of the local environments of aromatic residues. 31 The spectrum of BSA at pH 7 showed two peaks in the region from 270 to 300 nm: 285.3 nm due to both Trp and Tyr residue contributions and 277.8 nm primarily from Tyr residues (Fig. 8) . The spectra of the protein at pH 5 and 7 were nearly superimposable, signifying that there were minimal differences in the tertiary structure of BSA under these solution conditions at least in terms of local Tyr and Trp environment. In contrast, the spectrum of BSA under pH 2 solution conditions demonstrated a large blue shift in both of the second derivative peaks and the appearance of a third peak (291 nm) that was previously undetectable and largely attributed to Trp. This change in the peak positions indicates that the aromatic residues were much more solvent exposed at pH 2 when compared to pH 5 or 7. 31 In fact, the second derivative peak positions of BSA at pH 2 closely approach the positions of the protein denatured by 5.5 M GdnHCl (Tab. 3). There was a noticeable difference in peak positions between the pH 2 samples prepared at low-and high-ionic strength; BSA at pH 2 and high-ionic strength showed somewhat less blue-shifting in the second derivative absorbance data. Following a similar trend seen in the spectroscopic analysis of the secondary structure, the addition of 150 mM NaCl helped to maintain the native conformation of BSA when exposed to acidic solution conditions, although not nearly to the extent observed in secondary structure analyses.
The structural changes observed with BSA at pH 2 can be explained by acid denaturation of the protein. The structure of BSA is pH sensitive and the protein undergoes a structural transition at pH 2.7 to form a partially unfolded state. 26, 27 Under acidic conditions (pH 2), all of the ionizable protein groups (pK a > 3) are protonated and charge repulsion drives the unfolding of the molecule. 32 Often, acid denaturation results in severe loss in native tertiary structure though the secondary structure may or may not be disturbed. 33, 34 Consistent with acid denaturation of proteins, BSA samples prepared under acidic solution conditions (pH 2) exhibited a moderate disruption in the secondary structure, characterized by a loss of native a-helical content and an increase in turn as well as unordered structures in both FTIR (Fig. 6 ) and far UV CD spectra (Fig. 7) . The tertiary structure of BSA at pH 2, however, was greatly compromised. The second derivative UV absorbance spectrum of BSA at pH 2 more closely resembled BSA unfolded by 5.5 M GdnHCl rather than native BSA, suggesting a substantial extent of unfolding in the tertiary structure (Tab. 3).
The structural consequences of acid denaturation contribute to the instability of BSA at pH 2 in terms of both physical and chemical degradation pathways. The Lumry-Eyring model describes protein aggregation as a two-step process that is initiated by a conformational change in the protein leading to the formation of an aggregate-prone intermediate. 35 These species then undergo an assembly process to generate protein aggregates. Acid denaturation of BSA under acidic conditions (pH 2) leads to partial unfolding of the protein.
During the first 24 h of incubation at pH 2, BSA quickly adopts a partially unfolded conformation characterized by a loss in a-helix structure as observed by FTIR analysis (Fig. 5) . This aciddenatured state is an aggregate prone intermediate that instigates soluble aggregation and, in some cases, the formation of protein gels. Partial unfolding of the protein also contributes to the chemical degradation observed in this study. Under acidic conditions, the protein backbone is susceptible to peptide bond hydrolysis. Peptide bonds that contain Asp residues have been reported to hydrolyze more than 100 times more rapidly than other peptide bonds, 36 of which AspPro bonds the most sensitive to hydrolysis. 25 In the native conformation, a limited number of such bonds are accessible and easily hydrolyzed. Upon unfolding, previously inaccessible regions of the protein become solvent exposed and vulnerable to hydrolysis reactions. BSA contains 2 Asp-Pro and 4 Pro-Asp linkages, 26 hydrolysis of which could generate the fragments detected by SDS-PAGE (Fig. 2B) . Peptide bond hydrolysis is detectable throughout the incubation period at pH 2 though soluble aggregation only occurs in the first 2 weeks of the incubation. This suggests that the soluble aggregates that do not form protein gels are eventually hydrolyzed to peptide fragments.
Proteins that are extensively unfolded at pH 2 have been observed to regain some native structure in the presence of salt or by further titration with acid. 33 We observed that the addition of 150 mM NaCl significantly reduced the perturbations in the secondary structure of BSA at pH 2. Structural changes in the secondary structure of BSA at pH 2, including loss of a-helix content and an increase in unordered structure, were less severe in the presence of 150 mM NaCl in both FTIR (Fig. 6 ) and far UV CD analyses (Fig. 7) . A similar though less dramatic effect was also seen with the tertiary structure of the protein as noted by the reduction in the degree of blue shifting in the second derivative absorbance spectra (Fig. 8) . Salt-dependent refolding of acid-denatured proteins is primarily attributed to anion binding. 33 It is likely that electrostatic interactions between the chloride anions and the protonated sites on the protein molecule provided a ''masking'' effect of the repulsive positive charges, this allowing the protein to adopt a more native-like conformation. 37 Charge masking can also affect the colloidal stability of the protein and, therefore, may be responsible for the differences in BSA aggregation and gel formation at pH 2. Positive charges on the surface of the protein at pH 2 contribute to unfavorable protein-protein interactions due to repulsive charges between molecules. Upon the addition of salt, however, the interaction between protein molecules would become more favorable as a result of charge masking. Protein aggregation is an assembly process dependent upon proteinprotein interactions, and it would be therefore expected that aggregation would proceed more rapidly under conditions in which such interactions are more favorable. 37 We observed that BSA samples prepared at high-ionic strength degraded slightly faster (Fig. 1) and were more likely to form protein gels (Tab. 1) when compared to samples prepared at low-ionic strength, most likely the result of charge masking on colloidal stability.
CONCLUSIONS
In this study, we have examined how BSA rapidly degrades during incubation under acidic solution conditions in detail. Our work shows that the acid denaturation of BSA at pH 2 leads to substantial loss of native tertiary structure. Such changes in the conformation of the protein result in aggregation and increased peptide bond hydrolysis, providing the basis of instability observed in the current study as well as prior work. 13 The great similarity between the degradation products observed with BSA encapsulated within PLGA millicylinders and that induced by acidic (pH 2) solution conditions indicate that acidification within PLGA during release leads to the acid denaturation of BSA and consequent degradation of the protein.
Future development of PLGA delivery systems for controlled release of protein therapeutics must b ND denotes that no peak was detected at that position under the solution conditions described.
BSA DEGRADATION UNDER ACIDIC CONDITIONS take into account the conformational stability of the protein. We have shown that BSA loses native structure and is, therefore, susceptible to degradation under acidic conditions that may exist in the internal PLGA pores during the release phase due to the erosion of the matrix, 19, 20 and may also be representative of acid-labile proteins in general. Stabilization strategies employed to increase native BSA structure within PLGA devices have demonstrated greater success during release than with systems in which the native structure has been left to chance. For example, the use of trehalose during encapsulation of BSA within PLGA microspheres improved both the preservation of native protein structure as well as release of native protein from the device. 38 The incorporation of poorly-water soluble bases, such as Mg(OH) 2 , has also been shown to dramatically increase the release of BSA from PLGA systems by controlling the microclimate pH. 12, 13 We anticipate that such stabilization strategies will be important in the future development of successful controlled-release systems for therapeutic proteins.
